Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$8.96 - $14.7 $81,446 - $133,623
9,090 Added 6.19%
156,024 $1.76 Million
Q2 2022

Jul 29, 2022

BUY
$6.52 - $13.24 $42,979 - $87,278
6,592 Added 4.7%
146,934 $1.86 Million
Q1 2022

May 10, 2022

BUY
$6.2 - $7.87 $127,645 - $162,027
20,588 Added 17.19%
140,342 $982,000
Q4 2021

Feb 14, 2022

BUY
$5.13 - $7.89 $74,651 - $114,815
14,552 Added 13.83%
119,754 $859,000
Q3 2021

Nov 10, 2021

BUY
$4.89 - $7.82 $245,668 - $392,868
50,239 Added 91.41%
105,202 $547,000
Q2 2021

Aug 09, 2021

BUY
$4.61 - $6.83 $205,117 - $303,894
44,494 Added 425.01%
54,963 $341,000
Q1 2021

May 05, 2021

BUY
$6.19 - $16.0 $64,803 - $167,504
10,469 New
10,469 $77,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $10.4M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Avidian Wealth Solutions, LLC Portfolio

Follow Avidian Wealth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.